What is Tissx?
Tissx operates at the intersection of biotechnology and precision manufacturing, specializing in the development and supply of high-grade tissue-based products. The company provides critical components for cardiac, vascular, and specialty surgical applications, including fixed tissue pericardial patches and advanced heart valve repair technologies. By maintaining an ISO-certified facility, Tissx serves as a vital partner for medical device firms, offering OEM services that accelerate the development of bio-prosthetic therapies. Their market position is defined by a commitment to quality control and a collaborative approach to engineering tailored surgical solutions, effectively reducing the time-to-market for life-saving medical devices.
How much funding has Tissx raised?
Tissx has raised a total of $36K across 1 funding round:
Debt
$36K
Debt (2021): $36K with participation from PPP
Key Investors in Tissx
PPP
Public-Private Partnership
What's next for Tissx?
With the infusion of $36K, Tissx is poised to transition from its current operational baseline toward broader market penetration and enhanced R&D capabilities. The strategic deployment of this capital will likely focus on scaling production capacity to meet the rising demand for specialized tissue-based surgical components. Furthermore, the company is expected to leverage its existing OEM infrastructure to forge deeper partnerships within the global medical device ecosystem. As Tissx advances through this growth phase, the focus will remain on maintaining rigorous quality standards while expanding its portfolio of cardiac and vascular repair products to address unmet clinical needs in the surgical sector.
See full Tissx company page
